Literature DB >> 9445123

Management and prevention of cardiovascular hemorrhage associated with mediastinitis.

G Georgiade1, T A Levan, J Anthony, N Oldham, H Julio, C Milano, E Ritter.   

Abstract

OBJECTIVE: To elucidate the causes of cardiovascular hemorrhage associated with mediastinitis and to review recommendations for prevention and treatment. SUMMARY BACKGROUND DATA: Mediastinal debridement with immediate or early coverage using healthy, vascularized tissue has lead to greatly reduced morbidity and mortality for patients with mediastinitis. Myocardial hemorrhage has been anecdotally reported. PATIENTS AND METHODS: Over a 36-month period, 7 patients developed massive cardiovascular bleeding after undergoing debridement for poststernotomy mediastinitis. Causes included puncture or erosion by a sternal edge in three and tearing at the myocardial-sternal interface in four.
RESULTS: Five patients survived and remain infection-free at an average of 24 months of follow-up. In these patients, ventricular defects were closed with pledgeted sutures and muscle transposition was used concomitantly to reinforce the repair. This involved a slide of the left pectoralis major muscle and turnover of the right pectoralis in three patients, bilateral sliding in one patient, and bilateral pectoralis and an omental flap in one patient who required additional coverage of the lower mediastinum.
CONCLUSIONS: When a patient who has undergone mediastinal debridement shows evidence of significant bleeding, we recommend application of pressure for control of hemorrhage, expeditious return to an operating room with available cardiopulmonary bypass, and immediate muscle coverage with healthy, well-vascularized tissue. Finally, early sternectomy might largely prevent this life-threatening complication.

Entities:  

Mesh:

Year:  1998        PMID: 9445123      PMCID: PMC1191185          DOI: 10.1097/00000658-199801000-00021

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  8 in total

1.  Successful surgical treatment of postinfarction external cardiac rupture.

Authors:  G M FitzGibbon; G D Hooper; H A Heggtveit
Journal:  J Thorac Cardiovasc Surg       Date:  1972-04       Impact factor: 5.209

2.  Reoperation for myocardial revascularization.

Authors:  F D Loop; R L Thurer; B W Lytle; D M Cosgrove
Journal:  World J Surg       Date:  1978-11       Impact factor: 3.352

3.  Experimental use of intercostal muscle flaps for repair of induced cardiac defects.

Authors:  C Papp; P Parker; C Boeheim; J B McCraw
Journal:  J Thorac Cardiovasc Surg       Date:  1985-08       Impact factor: 5.209

4.  Comparison of the effect of bacterial inoculation in musculocutaneous and random-pattern flaps.

Authors:  N Chang; S J Mathes
Journal:  Plast Reconstr Surg       Date:  1982-07       Impact factor: 4.730

5.  [Delayed sternal closure following open-heart surgery in infants and children].

Authors:  F Oguma; H Miyamura; H Kanazawa; S Eguchi
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1990-03

6.  Primary treatment of the infected sternotomy wound with muscle flaps: a review of 211 consecutive cases.

Authors:  F Nahai; R P Rand; T R Hester; J Bostwick; M J Jurkiewicz
Journal:  Plast Reconstr Surg       Date:  1989-09       Impact factor: 4.730

7.  Delayed sternal closure. An improved method of dealing with complications after cardiopulmonary bypass.

Authors:  M Josa; S F Khuri; N S Braunwald; M F VanCisin; M P Spencer; D A Evans; E M Barsamian
Journal:  J Thorac Cardiovasc Surg       Date:  1986-04       Impact factor: 5.209

8.  Comparison of operative mortality and morbidity for initial and repeat coronary artery bypass grafting: The Coronary Artery Surgery Study (CASS) registry experience.

Authors:  E D Foster; L D Fisher; G C Kaiser; W O Myers
Journal:  Ann Thorac Surg       Date:  1984-12       Impact factor: 4.330

  8 in total
  1 in total

1.  Laparoscopic harvest of omental flaps for reconstruction of complex mediastinal wounds.

Authors:  Jihad R Salameh; Deborah A Chock; John J Gonzalez; Suresh Koneru; Jeffrey L Glass; Morris E Franklin
Journal:  JSLS       Date:  2003 Oct-Dec       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.